The relationship between oxygen therapy, drug therapy, and COVID-19 mortality
Ling Yang, Guoxi Chen, Yuyang Cai, Ye An, Xiaopan Li, Ying Chen, Cheng Xu, Chen Ji, Xing Lan, Yaling Wang, Hai Huang, Li Han
Open Medicine, doi:10.1515/med-2022-0569
Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 . We conducted a retrospective study of COVID-19 inpatients in Wuhan Pulmonary Hospital (Wuhan, China) from January 1 to February 29, 2020. The subjects were divided into four groups due to different treatment regimes. We used the Kaplan-Meier method to determine the cumulative rates of in-hospital death and the Cox proportional hazard model to calculate the risk factors and corresponding hazard ratios. A total of 185 patients were included in this study. The median age of the patients was 62 years, including 94 men and 91 women. Kaplan-Meier analysis demonstrated that mortality was higher in older patients, higher in men, and lower in the low-flow oxygen therapy group. Body mass index (BMI) had no influence on mortality, as well as high flow oxygen therapy, Lopinavir-ritonavir (LPV/r) therapy, and the interferon-alpha add LPV/r therapy. Cox proportional hazard regression confirmed that the low flow oxygen therapy was independent protective factor for in-hospital death after adjusting for age, gender, and BMI. In conclusion, the mortality was higher in older patients, higher in men, and lower in the low-flow oxygen therapy group. BMI had no influence on mortality, as well as high flow oxygen therapy, LPV/r therapy, and interferon-alpha add LPV/r therapy.
Abbreviations
Conflict of interest: The authors declare that they have no competing interest.
References
Mo, Xing, Xiao, Deng, Zhao et al., Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China, Clin Infect Dis,
doi:10.1093/cid/ciaa270
Wang, Pan, Tan, Xu, Ho, Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China, Int J Environ Res Public Health,
doi:10.3390/ijerph17051729
Wu, Liu, Zhao, Liu, Wang, Clinical characteristics of imported cases of COVID-19 in Jiangsu Province: a multicenter descriptive study, Clin Infect Dis,
doi:10.1093/cid/ciaa199
Zeng, Xu, He, Tang, Li et al., Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia, Chin Med J,
doi:10.1097/CM9.0000000000000790
Zhao, Cao, Chong, Gao, Lou et al., The timevarying serial interval of the coronavirus disease (COVID-19) and its gender-specific difference: A data-driven analysis using public surveillance data in Hong Kong and Shenzhen, China from January 10 to, Infect Control Hospital Epidemiol,
doi:10.1017/ice.2020.64
{ 'indexed': {'date-parts': [[2022, 12, 7]], 'date-time': '2022-12-07T06:01:23Z', 'timestamp': 1670392883193},
'reference-count': 12,
'publisher': 'Walter de Gruyter GmbH',
'issue': '1',
'license': [ { 'start': { 'date-parts': [[2022, 1, 1]],
'date-time': '2022-01-01T00:00:00Z',
'timestamp': 1640995200000},
'content-version': 'unspecified',
'delay-in-days': 0,
'URL': 'http://creativecommons.org/licenses/by/4.0'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'published-print': {'date-parts': [[2022, 11, 22]]},
'abstract': '<jats:title>Abstract</jats:title>\n'
' <jats:p>Since December, 2019, Wuhan, China, has experienced an outbreak of '
'coronavirus disease 2019 (COVID-19). We conducted a retrospective study of COVID-19 '
'inpatients in Wuhan Pulmonary Hospital (Wuhan, China) from January 1 to February 29, 2020. '
'The subjects were divided into four groups due to different treatment regimes. We used the '
'Kaplan–Meier method to determine the cumulative rates of in-hospital death and the Cox '
'proportional hazard model to calculate the risk factors and corresponding hazard ratios. A '
'total of 185 patients were included in this study. The median age of the patients was 62 '
'years, including 94 men and 91 women. Kaplan–Meier analysis demonstrated that mortality was '
'higher in older patients, higher in men, and lower in the low-flow oxygen therapy group. Body '
'mass index (BMI) had no influence on mortality, as well as high flow oxygen therapy, '
'Lopinavir–ritonavir (LPV/r) therapy, and the interferon-alpha add LPV/r therapy. Cox '
'proportional hazard regression confirmed that the low flow oxygen therapy was independent '
'protective factor for in-hospital death after adjusting for age, gender, and BMI. In '
'conclusion, the mortality was higher in older patients, higher in men, and lower in the '
'low-flow oxygen therapy group. BMI had no influence on mortality, as well as high flow oxygen '
'therapy, LPV/r therapy, and interferon-alpha add LPV/r therapy.</jats:p>',
'DOI': '10.1515/med-2022-0569',
'type': 'journal-article',
'created': { 'date-parts': [[2022, 11, 22]],
'date-time': '2022-11-22T14:25:57Z',
'timestamp': 1669127157000},
'page': '1833-1839',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'The relationship between oxygen therapy, drug therapy, and COVID-19 mortality',
'prefix': '10.1515',
'volume': '17',
'author': [ { 'given': 'Ling',
'family': 'Yang',
'sequence': 'first',
'affiliation': [ { 'name': 'Department of Geriatrics, Shanghai Fourth People’s Hospital '
'Affiliated to Tongji University , Shanghai , China'}]},
{ 'given': 'Guoxi',
'family': 'Chen',
'sequence': 'additional',
'affiliation': [ { 'name': 'Tuberculosis department, Wuhan Pulmonary Hospital , Wuhan , '
'China'}]},
{ 'given': 'Yuyang',
'family': 'Cai',
'sequence': 'additional',
'affiliation': [ { 'name': 'School of Public Health, Shanghai Jiaotong University School of '
'Medicine , Shanghai , China'}]},
{ 'given': 'Ye',
'family': 'An',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Geriatrics, Shanghai Jiaotong University School of '
'Medicine, Xinhua Hospital , Shanghai , China'}]},
{ 'given': 'Xiaopan',
'family': 'Li',
'sequence': 'additional',
'affiliation': [ { 'name': 'Pudong Institute of Preventive Medicine, Fudan University , '
'Shanghai , China'}]},
{ 'given': 'Ying',
'family': 'Chen',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Geriatrics, Shanghai Jiaotong University School of '
'Medicine, Xinhua Hospital , Shanghai , China'}]},
{ 'given': 'Cheng',
'family': 'Xu',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Geriatrics, Shanghai Jiaotong University School of '
'Medicine, Xinhua Hospital , Shanghai , China'}]},
{ 'given': 'Chen',
'family': 'Ji',
'sequence': 'additional',
'affiliation': [ { 'name': 'Warwick Clinical Trials Unit, Warwick Medical School , Warwick , '
'Great Britain'}]},
{ 'given': 'Xing',
'family': 'Lan',
'sequence': 'additional',
'affiliation': [ { 'name': 'Tuberculosis department, Wuhan Pulmonary Hospital , Wuhan , '
'China'}]},
{ 'given': 'Yaling',
'family': 'Wang',
'sequence': 'additional',
'affiliation': [ { 'name': 'Tuberculosis department, Wuhan Pulmonary Hospital , Wuhan , '
'China'}]},
{ 'given': 'Hai',
'family': 'Huang',
'sequence': 'additional',
'affiliation': [ { 'name': 'Tuberculosis department, Wuhan Pulmonary Hospital , Wuhan , '
'China'}]},
{ 'given': 'Li',
'family': 'Han',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Geriatrics, Shanghai Jiaotong University School of '
'Medicine, Xinhua Hospital , Shanghai , China'}]}],
'member': '374',
'published-online': {'date-parts': [[2022, 11, 22]]},
'reference': [ { 'key': '2022120618374797156_j_med-2022-0569_ref_001',
'unstructured': 'Chinese researchers reveal draft genome of virus implicated in Wuhan '
'pneumonia outbreak. '
'(https://www.sciencemag.org/news/2020/01/chinese-researchers-reveal-draft-genome-virus-implicated-wuhan-pneumonia-outbreak).'},
{ 'key': '2022120618374797156_j_med-2022-0569_ref_002',
'doi-asserted-by': 'crossref',
'unstructured': 'Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus '
'from patients with pneumonia in China, 2019. N Engl J Med. '
'2020;382:727–33. 10.1056/NEJMoa2001017.Epub2020.',
'DOI': '10.1056/NEJMoa2001017'},
{ 'key': '2022120618374797156_j_med-2022-0569_ref_003',
'unstructured': 'WHO Director-General’s Remarks at the Media Briefing on 2019-nCoV on 11 '
'February 2020. '
'(https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020).'},
{ 'key': '2022120618374797156_j_med-2022-0569_ref_004',
'doi-asserted-by': 'crossref',
'unstructured': 'Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission '
'dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N '
'Engl J Med. 2020;382(13):1199–207. 10.1056/NEJMoa2001316.Epub2020.',
'DOI': '10.1056/NEJMoa2001316'},
{ 'key': '2022120618374797156_j_med-2022-0569_ref_005',
'doi-asserted-by': 'crossref',
'unstructured': 'Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. '
'First case of 2019 novel coronavirus in the United States. N Engl J Med. '
'2020;382(10):929–36. 10.1056/NEJMoa2001191.Epub2020.',
'DOI': '10.1056/NEJMoa2001191'},
{ 'key': '2022120618374797156_j_med-2022-0569_ref_006',
'doi-asserted-by': 'crossref',
'unstructured': 'Zeng YM, Xu XL, He XQ, Tang SQ, Li Y, Huang YQ, et al. Comparative '
'effectiveness and safety of ribavirin plus interferon-alpha, '
'lopinavir/ritonavir plus interferon-alpha and ribavirin plus '
'lopinavir/ritonavir plus interferon-alphain in patients with mild to '
'moderate novel coronavirus pneumonia. Chin Med J. 2020;133(9):1132–4. '
'10.1097/CM9.0000000000000790.',
'DOI': '10.1097/CM9.0000000000000790'},
{ 'key': '2022120618374797156_j_med-2022-0569_ref_007',
'doi-asserted-by': 'crossref',
'unstructured': 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of '
'Lopinavir–Ritonavir in adults hospitalized with severe Covid-19. N Engl '
'J Med. 2020;382(19):1787–99. 10.1056/NEJMoa2001282.Epub2020.',
'DOI': '10.1056/NEJMc2008043'},
{ 'key': '2022120618374797156_j_med-2022-0569_ref_008',
'doi-asserted-by': 'crossref',
'unstructured': 'Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical '
'characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin '
'Infect Dis. 2020;73(11):e4208–213. 10.1093/cid/ciaa270.',
'DOI': '10.1093/cid/ciaa270'},
{ 'key': '2022120618374797156_j_med-2022-0569_ref_009',
'doi-asserted-by': 'crossref',
'unstructured': 'Wang C, Pan R, Wan X, Tan Y, Xu L, Ho C, et al. Immediate psychological '
'responses and associated factors during the initial stage of the 2019 '
'coronavirus disease (COVID-19) epidemic among the general population in '
'China. Int J Environ Res Public Health. 2020;17(5):1729. '
'10.3390/ijerph17051729.',
'DOI': '10.3390/ijerph17051729'},
{ 'key': '2022120618374797156_j_med-2022-0569_ref_010',
'doi-asserted-by': 'crossref',
'unstructured': 'Wenham C, Smith J, Morgan R. COVID-19: the gendered impacts of the '
'outbreak. Lancet (London, Engl). 2020;395:846–8. '
'10.1016/s0140-6736(20)30526-2.Epub2020.',
'DOI': '10.1016/S0140-6736(20)30526-2'},
{ 'key': '2022120618374797156_j_med-2022-0569_ref_011',
'doi-asserted-by': 'crossref',
'unstructured': 'Zhao S, Cao P, Chong MK, Gao D, Lou Y, Ran J, et al. The time-varying '
'serial interval of the coronavirus disease (COVID-19) and its '
'gender-specific difference: A data-driven analysis using public '
'surveillance data in Hong Kong and Shenzhen, China from January 10 to '
'February 15, 2020. Infect Control Hospital Epidemiol. 2020;10(5):1–8. '
'10.1017/ice.2020.64.',
'DOI': '10.1017/ice.2020.64'},
{ 'key': '2022120618374797156_j_med-2022-0569_ref_012',
'doi-asserted-by': 'crossref',
'unstructured': 'Wu J, Liu J, Zhao X, Liu C, Wang W, Wang D, et al. Clinical '
'characteristics of imported cases of COVID-19 in Jiangsu Province: a '
'multicenter descriptive study. Clin Infect Dis. 2020;71(15):706–12. '
'10.1093/cid/ciaa199.',
'DOI': '10.1093/cid/ciaa199'}],
'container-title': 'Open Medicine',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.degruyter.com/document/doi/10.1515/med-2022-0569/xml',
'content-type': 'application/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://www.degruyter.com/document/doi/10.1515/med-2022-0569/pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2022, 12, 6]],
'date-time': '2022-12-06T22:53:26Z',
'timestamp': 1670367206000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.degruyter.com/document/doi/10.1515/med-2022-0569/html'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2022, 1, 1]]},
'references-count': 12,
'journal-issue': { 'issue': '1',
'published-online': {'date-parts': [[2022, 11, 22]]},
'published-print': {'date-parts': [[2022, 11, 22]]}},
'alternative-id': ['10.1515/med-2022-0569'],
'URL': 'http://dx.doi.org/10.1515/med-2022-0569',
'relation': {},
'ISSN': ['2391-5463'],
'subject': ['General Medicine'],
'published': {'date-parts': [[2022, 1, 1]]}}